Literature DB >> 22504246

Stress-induced cardiomyopathy complicated by multiple organ failure following cephalosporin-induced anaphylaxis.

Ren-Hua Sun1, Bang-Chuan Hu, Qian Li.   

Abstract

Stress-induced cardiomyopathy, a reversible left ventricular dysfunction, has been reported following anaphylaxis; this clinical circumstance seems to be linked to elevated levels of circulating catecholamines. We present a 36-year-old woman diagnosed as stress-induced cardiomyopathy following ceftriaxone-induced anaphylaxis. After anaphylactic reaction, the patient initially presented with cardiogenic shock, and subsequently developed multiple organ failure. She recovered basically by multiple organ supportive therapies including intra-aortic balloon pump and continuous veno-venous hemofiltration. This case provides a unique opportunity to observe the triggering of stress-induced cardiomyopathy, and also it provides evidence to support the role of catecholamine in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504246     DOI: 10.2169/internalmedicine.51.6887

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Methylprednisolone-induced transient ventricular dysfunction.

Authors:  Hemal Bhatt; George Apergis; Archana Saxena
Journal:  Tex Heart Inst J       Date:  2015-02-01

2.  Initial clinical presentation of Takotsubo cardiomyopathy with-a focus on electrocardiographic changes: A literature review of cases.

Authors:  Erick Francisco Sanchez-Jimenez
Journal:  World J Cardiol       Date:  2013-07-26

Review 3.  A New Insight Into Sudden Cardiac Death in Young People: A Systematic Review of Cases of Takotsubo Cardiomyopathy.

Authors:  Yueyue Wang; Lei Xia; Xiaodong Shen; Guoxin Han; Dan Feng; Hongju Xiao; Yongzhi Zhai; Xin Chen; Yuanyuan Miao; Chunhong Zhao; Yingchan Wang; Mingguang Guo; Tanshi Li; Hai Yan Zhu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.